XIONG Jiali,LÜ Jingjun.Construction and multidimensional validation of a prognostic model for acute myeloid leukemia based on disulfidptosis‑associated lncRNAs[J].Medical Journal of Wuhan University,2025,46(11):1413-1421.
XIONG Jiali,LÜ Jingjun.Construction and multidimensional validation of a prognostic model for acute myeloid leukemia based on disulfidptosis‑associated lncRNAs[J].Medical Journal of Wuhan University,2025,46(11):1413-1421.DOI: 10.14188/j.1671-8852.2025.0032.
Construction and multidimensional validation of a prognostic model for acute myeloid leukemia based on disulfidptosis‑associated lncRNAs
To explore the expression profiles and prognostic value of double‑strand RNA death‑related long non‑coding RNAs (DRLs) in acute myeloid leukemia (AML) and to construct an effective prognostic model.
Methods
2
AML‑related transcriptomic data and corresponding clinical information were downloaded from The Cancer Genome Atlas (TCGA) website. DRLs associated with double‑strand RNA death were identified. A prognostic model was constructed using multivariable Cox regression analysis
and the model was validated through Kaplan‑Meier survival analysis
ROC curves
and concordance index (C‑index). Gene enrichment analysis
immune microenvironment analysis
mutation spectrum analysis
and drug sensitivity prediction were also conducted to investigate the biological differences and clinical characteristics between high‑ and low‑risk groups.
Results
2
The identified DRLs in the risk model included AC007556.1
AC020916.2
AC105345.1
AL139423.1
AL627171.2
and SNHG12
and a multivariable Cox regression model with good prognostic predictive ability was constructed.
Conclusion
2
The study revealed the significant role of DRLs in AML and provided an effective prognostic model with potential clinical application value.
关键词
Keywords
references
SHIMONY S , STAHL M , STONE R M . Acute myeloid leukemia: 2023 update on diagnosis, risk‑stratification, and management [J ] . Am J Hematol , 2023 , 98 ( 3 ): 502 ‑ 526 .
SWEET K , KOMROKJI R , PADRON E , et al . Phase Ⅰ clinical trial of selinexor in combination with daunorubicin and cytarabine in previously untreated poor‑risk acute myeloid leukemia [J ] . Clin Cancer Res , 2020 , 26 ( 1 ): 54 ‑ 60 .
KAYSER S , LEVIS M J . Updates on targeted therapies for acute myeloid leukaemia [J ] . Br J Haematol , 2022 , 196 ( 2 ): 316 ‑ 328 .
LIU X G , NIE L T , ZHANG Y L , et al . Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis [J ] . Nat Cell Biol , 2023 , 25 : 404 ‑ 414 .
PARDIEU B , PASANISI J , LING F , et al . Cystine uptake inhibition potentiates front‑line therapies in acute myeloid leukemia [J ] . Leukemia , 2022 , 36 : 1585 ‑ 1595 .
HUANG Z , ZHOU J K , PENG Y , et al . The role of long noncoding RNAs in hepatocellular carcinoma [J ] . Mol Cancer , 2020 , 19 ( 1 ): 77 .
LIAO H M , HE B C . Predictive value of cuproptosis and disulfidptosis‑related lncRNA in head and neck squamous cell carcinoma prognosis and treatment [J ] . Heliyon , 2024 , 10 ( 18 ): e37996 .
THAPA R , GOYAL A , GUPTA G , et al . Recent developments in the role of protocatechuic acid in neurodegenerative disorders [J ] . Excli J , 2023 , 22 : 595 ‑ 599 .
CHENG S , WANG X , YANG S , et al . Identification of novel disulfidptosis‑related lncRNA signatures to predict the prognosis and immune microenvironment of skin cutaneous melanoma patients [J ] . Skin Res Technol , 2024 , 30 ( 7 ): e13814 .
PENG C L , ZHAO X J , WEI C C , et al . LncRNA HOTAIR promotes colon cancer development by down‑regulating miRNA‑34a [J ] . Eur Rev Med Pharmacol Sci , 2019 , 23 ( 13 ): 5752 ‑ 5761 .
KAWASAKI Y , MIYAMOTO M , ODA T , et al . The novel lncRNA CALIC upregulates AXLto promote colon cancer metastasis [J ] . EMBO Rep , 2019 , 20 ( 8 ): e47052 .
FORREST M E , SAIAKHOVA A , BEARD L , et al . Colon cancer‑upregulated long non‑coding RNA lincDUSP regulates cell cycle genes and potentiates resistance to apoptosis [J ] . Sci Rep , 2018 , 8 : 7324 .
ZHOU L , ZHANG Q , DENG H , et al . The SNHG1‑centered CeRNA network regulates cell cycle and is a potential prognostic biomarker for hepatocellular carcinoma [J ] . Tohoku J Exp Med , 2022 , 258 ( 4 ): 265 ‑ 276 .
TAN Y T , LIN J F , LI T , et al . LncRNA‑mediated posttranslational modifications and reprogramming of energy metabolism in cancer [J ] . Cancer Commun (Lond) , 2021 , 41 ( 2 ): 109 ‑ 120 .
FAN Q , WU G B , CHEN M , et al . Analysis of disulfidptosis‑ and cuproptosis‑related LncRNAs in modulating the immune microenvironment and chemosensitivity in colon adenocarcinoma [J ] . IET Syst Biol , 2024 , 18 ( 2 ): 55 ‑ 75 .
SAMUEL V P , MOGLAD E , AFZAL M , et al . Exploring Ubiquitin‑specific proteases as therapeutic targets in Glioblastoma [J ] . Pathol Res Pract , 2024 , 260 : 155443 .
BHANSALI R S , PRATZ K W , LAI C . Recent advances in targeted therapies in acute myeloid leukemia [J ] . J Hematol Oncol , 2023 , 16 ( 1 ): 29 .
DIXON S J , LEMBERG K M , LAMPRECHT M R , et al . Ferroptosis: An iron‑dependent form of nonapoptotic cell death [J ] . Cell , 2012 , 149 ( 5 ): 1060 ‑ 1072 .
GALLUZZI L , VITALE I , AARONSON S A , et al . Molecular mechanisms of cell death: Recommendations of the nomenclature committee on cell death 2018 [J ] . Cell Death Differ , 2018 , 25 : 486 ‑ 541 .
WANG Y , LU G , XUE X , et al . Characterization and validation of a ferroptosis‑related LncRNA signature as a novel prognostic model for lung adenocarcinoma in tumor microenvironment [J ] . Front Immunol , 2022 , 13 : 903758 .
NÖSSING C , RYAN K M . 50 years on and still very much alive: 'Apoptosis: A basic biological phenomenon with wide‑ranging implications in tissue kinetics' [J ] . Br J Cancer , 2023 , 128 : 426 ‑ 431 .
YUAN M , WANG Y , SUN Q , et al . Identification of a nine immune‑related lncRNA signature as a novel diagnostic biomarker for hepatocellular carcinoma [J ] . Biomed Res Int , 2021 , 2021 : 9798231 .
WANG Y , XU R , ZHANG D , et al . Circ‑ZKSCAN1 regulates FAM83A expression and inactivates MAPK signaling by targeting miR‑330‑5p to promote non‑small cell lung cancer progression [J ] . Transl Lung Cancer Res , 2019 , 8 ( 6 ): 862 ‑ 875 .
REN W , YUAN Y , CHEN X , et al . Identification and validation of long non‑coding RNA LCIIAR as a biomarker in LUAD [J ] . Front Oncol , 2022 , 12 : 933071 .
LIU Y , LIANG L , JI L , et al . Potentiated lung adenocarcinoma (LUAD) cell growth, migration and invasion by lncRNA DARS‑AS1 via miR‑188‑5p/KLF12 axis [J ] . Aging (Albany NY) , 2021 , 13 ( 19 ): 2 3376‑ 23392 .
SHI D , QU Q , CHANG Q , et al . A five‑long non‑coding RNA signature to improve prognosis prediction of clear cell renal cell carcinoma [J ] . Oncotarget , 2017 , 8 ( 35 ): 5 8699‑ 58708 .
MA J , LIN X , WANG X , et al . Reconstruction and analysis of the immune‑related LINC00987/A2M axis in lung adenocarcinoma [J ] . Front Mol Biosci , 2021 , 8 : 644557 .
CHENG G , SONG Z , LIU Y , et al . Long noncoding RNA SNHG12 indicates the prognosis of prostate cancer and accelerates tumorigenesis via sponging miR‑133b [J ] . J Cell Physiol , 2020 , 235 ( 2 ): 1235 ‑ 1246 .
ZHAO G , WANG S , LIANG X , et al . Oncogenic role of long non‑coding RNA SNHG12 in gastric cancer cells by targeting miR‑16 [J ] . Exp Ther Med , 2019 , 18 ( 1 ): 199 ‑ 208 .
SUN D , FAN X H . LncRNA SNHG12 accelerates the progression of ovarian cancer via absorbing miRNA‑129 to upregulate SOX4 [J ] . Eur Rev Med Pharmacol Sci , 2019 , 23 ( 6 ): 2345 ‑ 2352 .
ZHOU B H , LI L J , LI Y J , et al . Long noncoding RNA SNHG12 mediates doxorubicin resistance of osteosarcoma via miR‑320a/MCL1 axis [J ] . Biomed Pharmacother , 2018 , 106 : 850 ‑ 857 .
ZHANG R , LIU Y , LIU H , et al . The long non‑coding RNA SNHG12 promotes gastric cancer by activating the phosphatidylinositol 3‑kinase/AKT pathway [J ] . Aging , 2019 , 11 ( 23 ): 1 0902‑ 10922 .
SONG J , WU X , MA R , et al . Long noncoding RNA SNHG12 promotes cell proliferation and activates Wnt/β‑catenin signaling in prostate cancer through sponging microRNA‑195 [J ] . J Cell Biochem , 2019 , 120 ( 8 ): 1 3066‑ 13075 .
WANG H , SHU L , NIU N , et al . Novel lncRNAs with diagnostic or prognostic value screened out from breast cancer via bioinformatics analyses [J ] . PeerJ , 2022 , 10 : e13641 .
ZHAO H Y , LIU X Q , YU L , et al . Comprehensive landscape of epigenetic‑dysregulated lncRNAs reveals a profound role of enhancers in carcinogenesis in BC subtypes [J ] . Mol Ther Nucleic Acids , 2021 , 23 : 667 ‑ 681 .